| Dr Ankur Saini, MD | |
|
6901 N 72nd St, Omaha, NE 68122-1709 | |
| (855) 524-4001 | |
| (402) 572-3206 |
| Full Name | Dr Ankur Saini |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 17 Years |
| Location | 6901 N 72nd St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144529397 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Immanuel | Omaha, NE | Hospital |
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alegent Creighton Clinic | 1951210418 | 827 |
| Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
A comprehensive review of evidence-informed health policymaking was recently launched in BioMed Central's journal Health Research Policy and Systems. This free supplement, entitled 'SUPPORT tools for evidence-informed health policymaking' provides an essential reference and set of tools that can be used by those involved in finding and using research evidence to support evidence-informed health policymaking.
A new study from American researchers shows that if dreams can be manipulated, memory could be enhanced and consolidated. The team tried a process called "dream incubation" using a device called Dormio in subjects for their study and published their novel findings.
Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.
Amid the anxiety and disruption caused by the COVID-19 pandemic, insurance customers across Asia are starting to adopt healthier lifestyle habits in terms of physical health and mental well-being, and increasingly recognise the convenience of digital technology in their day-to-day lives, according to a new survey by Manulife.
Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.
› Verified 9 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
A comprehensive review of evidence-informed health policymaking was recently launched in BioMed Central's journal Health Research Policy and Systems. This free supplement, entitled 'SUPPORT tools for evidence-informed health policymaking' provides an essential reference and set of tools that can be used by those involved in finding and using research evidence to support evidence-informed health policymaking.
A new study from American researchers shows that if dreams can be manipulated, memory could be enhanced and consolidated. The team tried a process called "dream incubation" using a device called Dormio in subjects for their study and published their novel findings.
Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.
Amid the anxiety and disruption caused by the COVID-19 pandemic, insurance customers across Asia are starting to adopt healthier lifestyle habits in terms of physical health and mental well-being, and increasingly recognise the convenience of digital technology in their day-to-day lives, according to a new survey by Manulife.
Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.
› Verified 9 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
A comprehensive review of evidence-informed health policymaking was recently launched in BioMed Central's journal Health Research Policy and Systems. This free supplement, entitled 'SUPPORT tools for evidence-informed health policymaking' provides an essential reference and set of tools that can be used by those involved in finding and using research evidence to support evidence-informed health policymaking.
A new study from American researchers shows that if dreams can be manipulated, memory could be enhanced and consolidated. The team tried a process called "dream incubation" using a device called Dormio in subjects for their study and published their novel findings.
Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.
Amid the anxiety and disruption caused by the COVID-19 pandemic, insurance customers across Asia are starting to adopt healthier lifestyle habits in terms of physical health and mental well-being, and increasingly recognise the convenience of digital technology in their day-to-day lives, according to a new survey by Manulife.
Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ankur Saini, MD 6901 N 72nd St, Omaha, NE 68122-1709 Ph: (855) 524-4001 | Dr Ankur Saini, MD 6901 N 72nd St, Omaha, NE 68122-1709 Ph: (855) 524-4001 |
News Archive
A comprehensive review of evidence-informed health policymaking was recently launched in BioMed Central's journal Health Research Policy and Systems. This free supplement, entitled 'SUPPORT tools for evidence-informed health policymaking' provides an essential reference and set of tools that can be used by those involved in finding and using research evidence to support evidence-informed health policymaking.
A new study from American researchers shows that if dreams can be manipulated, memory could be enhanced and consolidated. The team tried a process called "dream incubation" using a device called Dormio in subjects for their study and published their novel findings.
Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.
Amid the anxiety and disruption caused by the COVID-19 pandemic, insurance customers across Asia are starting to adopt healthier lifestyle habits in terms of physical health and mental well-being, and increasingly recognise the convenience of digital technology in their day-to-day lives, according to a new survey by Manulife.
Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.
› Verified 9 days ago
Dr. Anthony John Halat, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 855-524-4001 Fax: 402-572-3206 | |
Dr. William Andrew Abrahams, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 16901 Lakeside Hills Ct, Omaha, NE 68130 Phone: 402-717-8434 Fax: 402-717-7340 | |
Dr. Hafez Mohammad Ammar Abdullah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 42nd And Emile St Omaha, Omaha, NE 68198 Phone: 402-559-4000 | |
Dr. Vikas Kapoor, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-657-4936 | |
Dr. Alec Christine Hildenbrand, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 855-524-4001 Fax: 402-398-5589 | |
Nathan Christopher Birch, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 8303 Dodge St, Room 712, Omaha, NE 68114 Phone: 402-354-2360 | |
Dr. Bradley William Devrieze, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 855-524-4001 Fax: 402-398-5589 |